PVT1 and sarcoma: Despite the limitations mentioned above, our study is the first time to comprehensively investigate the clinical significance and prospective molecular regulatory mechanism of PVT1 in sarcoma using a whole genome RNA-seq dataset, discover its clinical significance in predicting the prognosis of sarcoma, and identify three potential PVT1 targeted drugs using CMap.